Topiramate and metabolic acidosis: an evolving story
- 1 September 2017
- journal article
- case report
- Published by Taylor & Francis in Hospital Practice
- Vol. 45 (5) , 192-195
Abstract
Topiramate is an anticonvulsant that is being increasingly used for a number of different off-label indications. Its inhibition of carbonic anhydrase isoenzymes can lead to metabolic acidosis, elevated urine pH, reduced urine citrate, and hypercalciuria, thereby creating a milieu that is ripe for calcium phosphate stone formation. In this review, we describe a case of topiramate-induced metabolic acidosis. We review the frequency of metabolic acidosis among children and adults, as well as the mechanism of hyperchloremic metabolic acidosis and renal tubular acidosis in topiramate users. Finally, we describe the long-term effects of topiramate-induced metabolic acidosis, including nephrolithiasis, nephrocalcinosis, and bone degradation. Patients who are prescribed topiramate should be carefully monitored for metabolic derangements, and they may benefit from alkali supplementation, or in extreme cases, discontinuation of the drug altogether.Keywords
This publication has 26 references indexed in Scilit:
- The frequency and severity of metabolic acidosis related to topiramateJournal of International Medical Research, 2016
- Topiramate for acute affective episodes in bipolar disorder in adultsCochrane Database of Systematic Reviews, 2016
- Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension PatientsJournal of Neuro-Ophthalmology, 2016
- Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic reviewBritish Journal of Clinical Pharmacology, 2014
- Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatientsDrug and Alcohol Dependence, 2009
- Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesityExpert Opinion on Emerging Drugs, 2008
- Topiramate monotherapy in epilepsy and migrainepreventionClinical Therapeutics, 2005
- Topiramate and metabolic acidosis: a case series and review of the literaturePediatric Anesthesia, 2005
- The New Antiepileptic DrugsJAMA, 2004
- Topiramate as an Inhibitor of Carbonic Anhydrase IsoenzymesEpilepsia, 2000